| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2023 | 25% | Piper Sandler | $10 → $7 | Maintains | Overweight |
| 08/02/2023 | 96.43% | JP Morgan | $10 → $11 | Maintains | Overweight |
| 08/02/2023 | 96.43% | RBC Capital | $10 → $11 | Maintains | Outperform |
| 08/02/2023 | 78.57% | Stifel | $9 → $10 | Maintains | Hold |
| 08/02/2023 | 78.57% | Piper Sandler | $9 → $10 | Maintains | Overweight |
| 07/20/2023 | 60.71% | Piper Sandler | → $9 | Upgrades | Neutral → Overweight |
| 07/17/2023 | 78.57% | RBC Capital | → $10 | Reiterates | Outperform → Outperform |
| 06/16/2023 | — | BTIG | Initiates Coverage On | → Neutral | |
| 06/15/2023 | 114.29% | Truist Securities | → $12 | Reiterates | Buy → Buy |
| 06/15/2023 | 60.71% | Stifel | → $9 | Reiterates | Hold → Hold |
| 03/07/2023 | 60.71% | Piper Sandler | → $9 | Reiterates | → Neutral |
| 02/23/2023 | 78.57% | RBC Capital | $9 → $10 | Maintains | Outperform |
| 02/23/2023 | 60.71% | Piper Sandler | → $9 | Reiterates | → Neutral |
| 10/19/2022 | 51.79% | Goldman Sachs | → $8.5 | Initiates Coverage On | → Neutral |
| 10/13/2022 | 114.29% | Truist Securities | $16 → $12 | Maintains | Buy |
| 08/12/2022 | 185.71% | Truist Securities | $25 → $16 | Maintains | Buy |
| 08/12/2022 | 60.71% | Stifel | $12 → $9 | Downgrades | Buy → Hold |
| 08/12/2022 | 60.71% | Piper Sandler | $13 → $9 | Downgrades | Overweight → Neutral |
| 07/18/2022 | 132.14% | Piper Sandler | $14 → $13 | Maintains | Overweight |
| 06/17/2022 | 275% | JP Morgan | $26 → $21 | Maintains | Overweight |
| 05/11/2022 | 203.57% | RBC Capital | $20 → $17 | Maintains | Outperform |
| 05/11/2022 | 150% | Piper Sandler | $20 → $14 | Maintains | Overweight |
| 02/24/2022 | 257.14% | Piper Sandler | $33 → $20 | Maintains | Overweight |
| 01/12/2022 | 489.29% | Piper Sandler | $39 → $33 | Maintains | Overweight |
| 08/11/2021 | 632.14% | Stifel | $27 → $41 | Upgrades | Hold → Buy |
| 08/11/2021 | 596.43% | Piper Sandler | $35 → $39 | Maintains | Overweight |
| 08/09/2021 | 578.57% | RBC Capital | $35 → $38 | Maintains | Outperform |
| 04/12/2021 | 507.14% | Truist Securities | → $34 | Initiates Coverage On | → Buy |
| 04/12/2021 | 542.86% | JP Morgan | → $36 | Initiates Coverage On | → Overweight |
| 04/12/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 04/12/2021 | 382.14% | Stifel | → $27 | Initiates Coverage On | → Hold |
| 04/12/2021 | 471.43% | RBC Capital | → $32 | Initiates Coverage On | → Outperform |
| 04/12/2021 | 525% | Piper Sandler | → $35 | Initiates Coverage On | → Overweight |
| 04/12/2021 | 400% | Goldman Sachs | → $28 | Initiates Coverage On | → Neutral |
What is the target price for Olo (OLO)?
The latest price target for Olo (NYSE: OLO) was reported by Piper Sandler on November 7, 2023. The analyst firm set a price target for $7.00 expecting OLO to rise to within 12 months (a possible 25.00% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Olo (OLO)?
The latest analyst rating for Olo (NYSE: OLO) was provided by Piper Sandler, and Olo maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Olo (OLO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Olo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Olo was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.
Is the Analyst Rating Olo (OLO) correct?
While ratings are subjective and will change, the latest Olo (OLO) rating was a maintained with a price target of $10.00 to $7.00. The current price Olo (OLO) is trading at is $5.60, which is out of the analyst's predicted range.